Literature DB >> 20484726

Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.

Bhanu Prakash Kolla1, Meghna Prabhdas Mansukhani, Román Barraza, John Michael Bostwick.   

Abstract

BACKGROUND: Dopamine agonists (DAs), long used in treating Parkinson's disease and effective in relieving symptoms of restless legs syndrome, have frequently been reported to induce problematic compulsive behaviors (e.g., obsessive gambling, hypersexuality) in individuals who had never had difficulties with such behaviors before.
OBJECTIVE: The authors report two cases that add to a small-but-growing literature suggesting that these drugs be dispensed with appropriate caution.
METHOD: The authors describe two patients seen in a psychiatric setting-one, after a suicide attempt, and one with depression-both resulting from intractable compulsive gambling.
RESULTS: In both instances, control of gambling was achieved: in one, when pramipexole was discontinued, and in the other, after substitution of ropinirole and addition of spiritual and support-group approaches. DISCUSSION: DAs stimulate pathways that govern reward behavior, including pleasure and addiction. Other reward behaviors, such as eating and sexual activity, may also be affected by DAs. These cases demonstrate a clear temporal relationship between initiation and behavioral change; patients and their caregivers should be alerted to the possibility of such changes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484726     DOI: 10.1176/appi.psy.51.3.271

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  6 in total

1.  Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.

Authors:  Cheryl Hankin; Daniel Lee; Diego Garcia-Borreguero; Zhaohui Wang
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

2.  Effects of the 5HT2C antagonist SB242084 on the pramipexole-induced potentiation of water contrafreeloading, a putative animal model of compulsive behavior.

Authors:  Chiara Schepisi; Lorenza De Carolis; Paolo Nencini
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

3.  Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans.

Authors:  Thomas F Newton; Colin N Haile; James J Mahoney; Ravi Shah; Christopher D Verrico; Richard De La Garza; Thomas R Kosten
Journal:  Psychiatry Res       Date:  2015-07-29       Impact factor: 3.222

4.  Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder.

Authors:  Graham K Murray; Franziska Knolle; Karen D Ersche; Kevin J Craig; Sanja Abbott; Shaila S Shabbir; Naomi A Fineberg; John Suckling; Barbara J Sahakian; Edward T Bullmore; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2019-06-14       Impact factor: 4.530

5.  Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System.

Authors:  Cristina Scavone; Barbara Stelitano; Concetta Rafaniello; Francesco Rossi; Liberata Sportiello; Annalisa Capuano
Journal:  J Gambl Stud       Date:  2020-03

Review 6.  Dopamine Agonists and Impulse Control Disorders: A Complex Association.

Authors:  Marie Grall-Bronnec; Caroline Victorri-Vigneau; Yann Donnio; Juliette Leboucher; Morgane Rousselet; Elsa Thiabaud; Nicolas Zreika; Pascal Derkinderen; Gaëlle Challet-Bouju
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.